Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19295122 | NANOPORE-BASED ANALYSIS OF ANALYTES | August 2025 | December 2025 | Allow | 4 | 0 | 0 | No | No |
| 19268022 | LINKED LIGATION | July 2025 | August 2025 | Allow | 1 | 0 | 0 | No | No |
| 19240880 | METHODS AND COMPOSITIONS FOR ISOLATING AN ANALYTE | June 2025 | August 2025 | Allow | 2 | 0 | 0 | No | No |
| 19212481 | METHOD FOR MAKING A PHYSICAL MAP OF BINDING EVENTS THAT ARE ON OR ON CELLS | May 2025 | July 2025 | Allow | 1 | 0 | 0 | No | No |
| 19082509 | LINKED LIGATION | March 2025 | July 2025 | Allow | 4 | 0 | 0 | No | No |
| 19082485 | LINKED LIGATION | March 2025 | May 2025 | Allow | 2 | 0 | 0 | No | No |
| 19029171 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | January 2025 | October 2025 | Allow | 9 | 1 | 0 | No | No |
| 18946611 | METHODS OF PREDICTING ENGRAFTMENT CAPABILITY OF DIFFERENTIATED NEURONAL PROGENITOR CELLS | November 2024 | February 2025 | Allow | 3 | 0 | 0 | No | No |
| 18912947 | MOLECULAR MARKERS FOR GERMPLASM IDENTIFICATION AND SELECTION OF CAROTENOID-RICH BAY SCALLOPS | October 2024 | August 2025 | Allow | 10 | 2 | 0 | No | No |
| 18889399 | METHODS FOR ISOLATING TARGET ANALYTES FROM URINE SAMPLES USING ATPS AND MAGNETIC BEADS | September 2024 | April 2025 | Allow | 7 | 0 | 1 | No | No |
| 18889404 | METHODS AND KITS USEFUL FOR DIAGNOSIS OF UROGENITAL CANCER | September 2024 | April 2025 | Allow | 7 | 0 | 1 | No | No |
| 18827295 | MICROFLUIDICS SYSTEM, DEVICE, AND METHODS FOR PERFORMING RAPID POLYMERASE CHAIN REACTION (PCR) PROTOCOLS | September 2024 | April 2025 | Allow | 8 | 0 | 1 | No | No |
| 18679053 | METHOD FOR BARCODING | May 2024 | September 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18677555 | COMPOSITION COMPRISING CELL ORIGINATION BARCODES FOR THE ANALYSIS OF BOTH PROTEIN AND NUCLEIC ACID FROM THE SAME CELL | May 2024 | August 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18663889 | METHODS AND DEVICES FOR SEQUENCING NUCLEIC ACIDS IN SMALLER BATCHES | May 2024 | January 2026 | Allow | 20 | 2 | 1 | No | No |
| 18591066 | METHODS AND COMPOSITIONS FOR THE EXTRACTION AND AMPLIFICATION OF NUCLEIC ACID FROM A SAMPLE | February 2024 | July 2025 | Abandon | 16 | 1 | 1 | No | No |
| 18536935 | DIGITAL ANALYTE ANALYSIS | December 2023 | December 2024 | Allow | 12 | 2 | 1 | Yes | No |
| 18529759 | PCR MEASURING METHOD AND MEASUREMENT DEVICE | December 2023 | March 2026 | Allow | 27 | 0 | 0 | No | No |
| 18509322 | PRIMER GROUP FOR SIMULTANEOUS DETECTION OF 15 PORCINE PATHOGENS THROUGH HIGH-THROUGHPUT TARGETED AMPLICON SEQUENCING AND USE THEREOF | November 2023 | December 2024 | Allow | 13 | 2 | 1 | Yes | No |
| 18037307 | MICROBE DETECTION METHOD USING FISH ANALYSIS | November 2023 | February 2026 | Allow | 33 | 0 | 0 | No | No |
| 18556472 | METHODS AND COMPOSITIONS FOR TREATING CELL SENESCENCE ACCUMULATION RELATED DISEASE | October 2023 | February 2026 | Allow | 28 | 0 | 0 | No | No |
| 18488255 | LINKED LIGATION | October 2023 | March 2026 | Allow | 29 | 0 | 0 | No | No |
| 18284550 | CAPTURE CONSTRUCT AND METHOD FOR DETECTING A PLURALITY OF ANALYTES | September 2023 | February 2026 | Allow | 28 | 0 | 0 | No | No |
| 18470979 | METHODS, SYSTEMS, AND COMPOSITIONS FOR COUNTING NUCLEIC ACID MOLECULES | September 2023 | March 2026 | Allow | 29 | 0 | 0 | No | No |
| 18465946 | METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING | September 2023 | June 2025 | Abandon | 21 | 0 | 0 | No | No |
| 18233283 | Systems, Methods, and Devices for Sample Collection, Stabilization and Preservation | August 2023 | February 2025 | Abandon | 18 | 1 | 1 | No | No |
| 18448493 | SOYBEAN TRANSGENIC EVENT MON87751 AND METHODS FOR DETECTION AND USE THEREOF | August 2023 | August 2025 | Allow | 24 | 1 | 0 | No | No |
| 18274974 | METHODS, COMPOSITIONS AND KITS TO IMPROVE SEEDING EFFICIENCY OF FLOW CELLS WITH POLYNUCLEOTIDES | July 2023 | January 2026 | Allow | 30 | 0 | 0 | No | No |
| 18358565 | METHODS FOR DETECTING RNA BINDING PROTEIN COMPLEXES | July 2023 | July 2025 | Allow | 24 | 0 | 0 | Yes | No |
| 18355932 | BIOMARKERS AND USES THEREOF | July 2023 | March 2025 | Allow | 20 | 0 | 0 | No | No |
| 18352701 | SEQUENCING KIT | July 2023 | July 2025 | Allow | 24 | 0 | 0 | Yes | No |
| 18221099 | NUCLEIC ACID AMPLIFICATION | July 2023 | August 2025 | Allow | 25 | 0 | 0 | No | No |
| 18252015 | METHOD FOR PRODUCING MIRNA LIBRARIES FOR MASSIVE PARALLEL SEQUENCING | June 2023 | November 2025 | Allow | 31 | 0 | 0 | No | No |
| 18204920 | HOMOPOLYMER PRIMERS FOR AMPLIFICATION OF POLYNUCLEOTIDES CREATED BY ENZYMATIC SYNTHESIS | June 2023 | April 2025 | Allow | 22 | 0 | 0 | No | No |
| 18322490 | METHODS FOR BARCODING MACROMOLECULES IN INDIVIDUAL CELLS | May 2023 | May 2025 | Allow | 24 | 0 | 1 | No | No |
| 18316575 | Complex Surface-Bound Transposome Complexes | May 2023 | July 2025 | Allow | 26 | 1 | 1 | Yes | No |
| 18316883 | METHYLATION ASSAY | May 2023 | January 2025 | Allow | 20 | 0 | 0 | No | No |
| 18313716 | SYNTHETIC NUCLEIC ACID SPIKE-INS | May 2023 | February 2026 | Allow | 33 | 2 | 1 | Yes | No |
| 18141553 | Methods and Systems for Extraction, Processing, and Detection of Nucleic Acids | May 2023 | March 2026 | Allow | 34 | 0 | 1 | No | No |
| 18310276 | ISOLATION AND DETECTION OF DNA FROM PLASMA | May 2023 | August 2025 | Allow | 27 | 1 | 0 | Yes | No |
| 18310266 | ISOLATION OF NUCLEIC ACIDS | May 2023 | June 2025 | Allow | 25 | 1 | 0 | No | No |
| 18303193 | Kelch Domain Containing 7B (KLHDC7B) Variants And Uses Thereof | April 2023 | November 2024 | Allow | 19 | 0 | 0 | No | No |
| 18135424 | METHODS AND KITS FOR DETERMINING THE EFFICIENCY OF PLASMA SEPARATION FROM WHOLE BLOOD | April 2023 | April 2025 | Allow | 24 | 1 | 0 | No | No |
| 18297994 | BRASSICA GAT EVENT AND COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND/OR DETECTION THEREOF | April 2023 | December 2025 | Allow | 32 | 2 | 0 | No | No |
| 18030412 | NUCLEIC ACID ENRICHMENT METHOD | April 2023 | September 2025 | Allow | 30 | 0 | 0 | No | No |
| 18129775 | DIGITAL TO BIOLOGICAL CONVERTER | March 2023 | December 2025 | Allow | 33 | 3 | 0 | No | No |
| 18190465 | PRIMERS FOR IMMUNE REPERTOIRE PROFILING | March 2023 | April 2025 | Allow | 25 | 1 | 0 | No | No |
| 18026255 | COMPOSITIONS AND METHODS FOR PRESERVING DNA METHYLATION | March 2023 | September 2025 | Allow | 30 | 0 | 0 | No | No |
| 18118573 | NON-INVASIVE PRENATAL DIAGNOSIS OF FETAL GENETIC CONDITION USING CELLULAR DNA AND CELL FREE DNA | March 2023 | November 2025 | Abandon | 32 | 2 | 0 | No | No |
| 18177750 | ON-SLIDE STAINING BY PRIMER EXTENSION | March 2023 | March 2025 | Allow | 24 | 0 | 1 | Yes | No |
| 18116013 | DEPLETION PROBES | March 2023 | October 2025 | Allow | 32 | 0 | 0 | No | No |
| 18020484 | Method for Targeted Nucleic Acid Cleavage | February 2023 | August 2025 | Allow | 30 | 0 | 0 | No | No |
| 18106189 | CELL BARCODING FOR SINGLE CELL SEQUENCING | February 2023 | August 2024 | Allow | 18 | 0 | 0 | Yes | No |
| 18104548 | METHODS, COMPOSITIONS, SYSTEMS, APPARATUSES AND KITS FOR NUCLEIC ACID AMPLIFICATION | February 2023 | March 2025 | Allow | 25 | 0 | 1 | No | No |
| 18159782 | RAMAN TESTING SYSTEM AND METHODS OF DETECTING PATHOGENS | January 2023 | February 2026 | Abandon | 36 | 1 | 0 | No | No |
| 18006566 | Biomarkers For Cognitive Conditions | January 2023 | February 2026 | Abandon | 36 | 0 | 1 | No | No |
| 18099865 | MULTIPLE READOUT SIGNALS FOR ANALYZING A SAMPLE | January 2023 | August 2025 | Allow | 31 | 0 | 0 | No | No |
| 18016049 | USE OF MICRORNA AS PANCREATIC CANCER BIOMARKER | January 2023 | January 2026 | Allow | 36 | 0 | 1 | No | No |
| 18152474 | DEVICES AND COMPOSITIONS FOR USE IN LUMINESCENT IMAGING OF MULTIPLE SITES WITHIN A PIXEL, AND METHODS OF USING THE SAME | January 2023 | February 2026 | Allow | 38 | 1 | 1 | No | No |
| 18094278 | SYSTEM AND METHOD FOR AUTOMATED SINGLE CELL PROCESSING | January 2023 | April 2025 | Allow | 28 | 0 | 1 | No | No |
| 18004365 | TARGETED DEPLETION OF NON-TARGET LIBRARY MOLECULES USING POISON PRIMERS DURING TARGET CAPTURE OF NEXT-GENERATION SEQUENCING LIBRARIES | January 2023 | December 2025 | Allow | 36 | 0 | 1 | No | No |
| 18149143 | METHOD AND SYSTEM FOR SAMPLING MATERIAL FROM CELLS | January 2023 | July 2025 | Allow | 30 | 2 | 0 | No | No |
| 18003883 | SCALABLE CIRCUIT FOR MOLECULAR DETECTION | December 2022 | August 2025 | Allow | 31 | 0 | 0 | No | No |
| 18147149 | METHOD OF DETERMINING LIMIT OF DETECTION AND LIMIT OF QUANTITATION IN NUCLEIC ACID DETECTION TEST | December 2022 | July 2025 | Allow | 31 | 0 | 0 | No | No |
| 18145163 | RAPID PURIFICATION OF HIGH QUALITY NUCLEIC ACIDS FROM BIOLOGICAL SAMPLES | December 2022 | March 2025 | Abandon | 27 | 0 | 1 | No | No |
| 18087259 | METHODS, COMPOSITIONS, AND KITS FOR DETECTING ALLELIC VARIANTS | December 2022 | May 2025 | Abandon | 28 | 0 | 1 | No | No |
| 18085457 | MRNA QUANTIFICATION METHODS | December 2022 | September 2025 | Allow | 33 | 0 | 0 | No | No |
| 18068868 | WAX-MICROSPHERE MATRIX COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | December 2022 | November 2025 | Allow | 35 | 0 | 1 | No | No |
| 18002168 | Tiled ClickSeq for Targeted Virus Whole Genome Sequencing | December 2022 | March 2025 | Allow | 27 | 1 | 1 | No | No |
| 18079681 | RESTRICTION DIGEST BASED SEQUENTIAL DECODING | December 2022 | July 2025 | Allow | 31 | 0 | 0 | No | No |
| 18073377 | USE OF DNA:RNA DUPLEX FRAGMENTATION | December 2022 | January 2026 | Allow | 37 | 0 | 1 | No | No |
| 17927525 | COMPOSITIONS AND METHODS FOR PRESERVING DNA METHYLATION | November 2022 | July 2025 | Allow | 32 | 0 | 0 | Yes | No |
| 17992304 | DIGITAL ANALYTE ANALYSIS | November 2022 | March 2025 | Allow | 27 | 2 | 1 | No | No |
| 17989814 | DROPLET INTERFACES IN ELECTRO-WETTING DEVICES | November 2022 | January 2025 | Allow | 26 | 1 | 1 | No | No |
| 17985410 | EMULSION BASED DRUG SCREENING | November 2022 | September 2025 | Abandon | 34 | 2 | 1 | No | No |
| 18052783 | METHOD OF REPLICATING OR AMPLIFYING CIRCULAR DNA | November 2022 | August 2024 | Allow | 21 | 0 | 0 | No | No |
| 17980960 | Using Hairpin Formation To Identify DNA and RNA Sequences Having A Target Nucleic Acid Sequence | November 2022 | December 2025 | Allow | 38 | 0 | 1 | No | No |
| 17977208 | METHODS FOR CHARACTERIZING COPY NUMBER VARIATION USING PROXIMITY-LITIGATION SEQUENCING | October 2022 | October 2024 | Allow | 23 | 1 | 0 | No | No |
| 17977393 | Exposome Tracker for Environmental Health | October 2022 | October 2025 | Allow | 35 | 0 | 1 | No | No |
| 17962603 | METHOD FOR NUCLEIC ACID DEPLETION | October 2022 | March 2025 | Allow | 29 | 1 | 1 | No | No |
| 17937968 | CELL-FREE BIOSENSORS TO DETECT CREATININE, CREATINE, AND SARCOSINE | October 2022 | December 2025 | Allow | 38 | 0 | 0 | No | No |
| 17959543 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | October 2022 | March 2025 | Abandon | 29 | 3 | 1 | No | No |
| 17916282 | METHODS FOR PRODUCING PLASMID DNA | September 2022 | July 2025 | Allow | 34 | 0 | 0 | No | No |
| 17932844 | NUCLEOTIDE TRANSIENT BINDING FOR SEQUENCING METHODS | September 2022 | July 2024 | Allow | 22 | 0 | 0 | No | No |
| 17911838 | NUCLEIC ACID AMPLIFICATION | September 2022 | February 2026 | Allow | 41 | 1 | 1 | No | No |
| 17945334 | METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING | September 2022 | September 2025 | Abandon | 36 | 2 | 0 | No | No |
| 17910149 | APPARATUS AND METHODS FOR MOLECULAR DIAGNOSTICS | September 2022 | December 2025 | Allow | 39 | 0 | 1 | No | No |
| 17905497 | METHOD FOR DETECTING CORONAVIRUS (SARS-CoV-2) | September 2022 | July 2025 | Allow | 35 | 0 | 1 | No | No |
| 17897498 | LINEAR COVALENTLY CLOSED VECTORS AND RELATED COMPOSITIONS AND METHODS THEREOF | August 2022 | June 2025 | Allow | 34 | 1 | 1 | No | No |
| 17822521 | SOLID PHASE EXTRACTION MATERIAL AND ITS USE FOR NUCLEIC ACID ENRICHMENT AND DETECTION | August 2022 | October 2024 | Allow | 26 | 1 | 1 | No | No |
| 17819824 | COMPOSITIONS AND METHODS FOR DETECTING CIRCULATING TUMOR DNA | August 2022 | May 2025 | Allow | 33 | 2 | 0 | Yes | Yes |
| 17799440 | NUCLEOBASE EDITORS AND METHODS OF USE THEREOF | August 2022 | June 2025 | Allow | 34 | 0 | 0 | No | No |
| 17904202 | QUANTITATIVE DETECTION METHOD FOR SIX ANTIBIOTIC DRUG RESISTANT GENES IN AQUATIC PRODUCT | August 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17816984 | STABILIZATION AND/OR COMPACTION OF NUCLEIC ACID STRUCTURES | August 2022 | May 2025 | Allow | 34 | 0 | 0 | No | No |
| 17877657 | METHODS FOR IN VITRO JOINING AND COMBINATORIAL ASSEMBLY OF NUCLEIC ACID MOLECULES | July 2022 | April 2025 | Allow | 32 | 0 | 1 | Yes | No |
| 17876893 | METHODS AND APPARATUS THAT INCREASE SEQUENCING-BY-BINDING EFFICIENCY | July 2022 | August 2024 | Allow | 25 | 0 | 0 | Yes | No |
| 17795104 | METHODS FOR IDENTIFICATION OF LIGAND-BLOCKING ANTIBODIES AND FOR DETERMINING ANTIBODY POTENCY | July 2022 | May 2025 | Allow | 34 | 0 | 0 | No | No |
| 17868131 | Diagnostic Methods and Markers for Bacterial Vaginosis | July 2022 | July 2024 | Allow | 24 | 0 | 0 | Yes | No |
| 17758906 | Compositions, Kits and Methods for Isolating Target Polynucleotides | July 2022 | December 2025 | Allow | 41 | 0 | 1 | No | No |
| 17863306 | DETECTION METHOD USING LATERAL-FLOW PAPER CHIP CAPABLE OF MULTI-NUCLEIC ACID COLORIMETRIC DETECTION WITH ONE-STEP | July 2022 | January 2026 | Abandon | 42 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PRIEST, AARON A.
With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 27.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PRIEST, AARON A works in Art Unit 1681 and has examined 93 patent applications in our dataset. With an allowance rate of 84.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 40 months.
Examiner PRIEST, AARON A's allowance rate of 84.9% places them in the 61% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by PRIEST, AARON A receive 2.54 office actions before reaching final disposition. This places the examiner in the 74% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by PRIEST, AARON A is 40 months. This places the examiner in the 23% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +14.5% benefit to allowance rate for applications examined by PRIEST, AARON A. This interview benefit is in the 53% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 22.0% of applications are subsequently allowed. This success rate is in the 27% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 28.6% of cases where such amendments are filed. This entry rate is in the 40% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 81.8% of appeals filed. This is in the 74% percentile among all examiners. Of these withdrawals, 44.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 48.0% are granted (fully or in part). This grant rate is in the 43% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 2.2% of allowed cases (in the 75% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.5% of allowed cases (in the 71% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.